Details

DSEN Abstract: What is the comparative effectiveness and safety of sitagliptin and NPH insulin for the management of type 2 diabetes not controlled by metformin plus sulfonylurea? - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
May 1, 2026 · edition #8
Timestamp
2026-05-01T09:40:56.037Z
Language
en
ID
1364738
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview